Danaher Corp (NYSE:DHR)

128.92
Delayed Data
As of Apr 01
 +0.22 / +0.17%
Today’s Change
119.60
Today|||52-Week Range
169.19
-16.00%
Year-to-Date
General Electric Sale of Biopharma Unit to Danaher Closes
Mar 31 / MotleyFool.com - Paid Partner Content
Stock Market News: This Top Coronavirus Stock Just Soared Again
Mar 23 / MotleyFool.com - Paid Partner Content
New Shutdown Repeal Dates and a Testing Breakthrough Could Be Game-Changers for the Market
Mar 30 / MotleyFool.com - Paid Partner Content
Early FDA Approval to Speed Up Coronavirus Testing
Mar 22 / MotleyFool.com - Paid Partner Content
FDA Approves New 5 Minute Test to Accelerate U.S. Coronavirus Response
Mar 28 / MotleyFool.com - Paid Partner Content
Why General Electric Stock Popped 6% on Friday
Mar 21 / MotleyFool.com - Paid Partner Content
Better Coronavirus Stock: Regeneron or Roche?
Mar 25 / MotleyFool.com - Paid Partner Content
GE and Danaher Get FTC Clearance for BioPharma Deal
Mar 20 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close128.70
Today’s open133.25
Day’s range128.05 - 135.38
Volume3,723,777
Average volume (3 months)9,100,949
Market cap$96.5B
Data as of 5:16pm ET, 04/01/2020

Growth & Valuation

Earnings growth (last year)-7.92%
Earnings growth (this year)+18.37%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)-9.96%
P/E ratio39.5
Price/Sales6.22
Price/Book3.36

Competitors

 Today’s
change
Today’s
% change
TMOThermo Fisher Scient...+0.48+0.17%
AAgilent Technologies...+0.08+0.12%
MTDMettler-Toledo Inter...+2.29+0.35%
WATWaters Corp+0.02+0.01%
Data as of 4:00pm ET, 04/01/2020

Financials

Next reporting dateApril 16, 2020
EPS forecast (this quarter)$1.03
Annual revenue (last year)$17.9B
Annual profit (last year)$2.6B
Net profit margin13.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Washington, District Of Columbia

Forecasts